Frances Crofts

1.1k total citations
13 papers, 951 citations indexed

About

Frances Crofts is a scholar working on Pharmacology, Cancer Research and Molecular Biology. According to data from OpenAlex, Frances Crofts has authored 13 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Frances Crofts's work include Carcinogens and Genotoxicity Assessment (8 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Glutathione Transferases and Polymorphisms (6 papers). Frances Crofts is often cited by papers focused on Carcinogens and Genotoxicity Assessment (8 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Glutathione Transferases and Polymorphisms (6 papers). Frances Crofts collaborates with scholars based in United States, Mali and France. Frances Crofts's co-authors include Seymour Garte, Greg Cosma, Paolo Toniolo, Diane Currie, Emanuela Taioli, Julie Trachman, Patricia A. Toniolo, Christopher J. Portier, Ying Li and Siné Bayo and has published in prestigious journals such as Carcinogenesis, Toxicology and Applied Pharmacology and Toxicology Letters.

In The Last Decade

Frances Crofts

12 papers receiving 925 citations

Peers

Countries citing papers authored by Frances Crofts

Since Specialization

Citations

This map shows the geographic impact of Frances Crofts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Crofts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Crofts more than expected).

Fields of papers citing papers by Frances Crofts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances Crofts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Crofts. The network helps show where Frances Crofts may publish in the future.

Co-authorship network of co-authors of Frances Crofts

This figure shows the co-authorship network connecting the top 25 collaborators of Frances Crofts. A scholar is included among the top collaborators of Frances Crofts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances Crofts. Frances Crofts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Critical period for a teratogenic VLA‐4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non‐teratogenic VLA‐4 antagonists 2004 ·Birth Defects Research Part B Developmental and Reproductive Toxicology ·Frances Crofts, Shashank Rohatagi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), P. Brunel, Thomas Hofmann, John A. Schmidt, May Wong, Peter Lockey, S Lerman, Robert L. Clark	13
2	Different embryo‐fetal toxicity effects for three VLA‐4 antagonists 2004 ·Birth Defects Research Part B Developmental and Reproductive Toxicology ·Frances Crofts, (unknown), (unknown), (unknown), (unknown), P. Brunel, (unknown), (unknown), Thomas Hofmann, S Lerman, Robert L. Clark	13
3	Characterization of the Dose–Response of CYP1B1, CYP1A1, and CYP1A2 in the Liver of Female Sprague–Dawley Rats Following Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin 1999 ·Toxicology and Applied Pharmacology ·Nigel J. Walker, Christopher J. Portier, Sigurd Lax, Frances Crofts, Ying Li, George W. Lucier, Thomas R. Sutter	87
4	Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1 1998 ·Carcinogenesis ·Frances Crofts	119
5	Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochrome P4501B1 1997 ·Carcinogenesis ·Frances Crofts	55
6	Distribution of Composite CYP1A1 Genotypes in Africans, African-Americans and Caucasians 1996 ·Human Heredity ·Seymour Garte, (unknown), Frances Crofts, Paolo Toniolo, Joel N. Buxbaum, Siné Bayo, Emanuela Taioli	44
7	Enhanced Risk of Lung and Prostate Adenocarcinoma in African-American Smokers Carrying a Novel Cypiai Gene Polymorphism 1996 ·Polycyclic aromatic compounds ·Emanuela Taioli, Frances Crofts, Julie Trachman, (unknown), Rita I. Demopoulos, Jean G. Ford, Seymour Garte	0
8	Racial differences in CYP1A1 genotype and function 1995 ·Toxicology Letters ·Emanuela Taioli, Frances Crofts, Julie Trachman, Siné Bayo, Paolo Toniolo, Seymour Garte	34
9	A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. 1995 ·PubMed ·Emanuela Taioli, Frances Crofts, Julie Trachman, Rita I. Demopoulos, Paolo Toniolo, Seymour Garte	44
10	Functional significance of different human CYPlAl genotypes 1994 ·Carcinogenesis ·Frances Crofts, (unknown), Julie Trachman, Greg Cosma, Diane Currie, Patricia A. Toniolo, Seymour Garte	265
11	A novel CYP1A1 gene polymorphism in African-Americans 1993 ·Carcinogenesis ·Frances Crofts, Greg Cosma, Diane Currie, Emanuela Taioli, Paolo Toniolo, Seymour Garte	100
12	Relationship between genotype and function of the human CYP1A1 gene 1993 ·Journal of Toxicology and Environmental Health ·Greg Cosma, Frances Crofts, Emanuela Taioli, Paolo Toniolo, Seymour Garte	125
13	Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. 1993 ·PubMed ·Greg Cosma, Frances Crofts, Diane Currie, Isaac Wirgin, Paolo Toniolo, Seymour Garte	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact